Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation

Maarten Naesens*, ESOT Working Group, Stefan Schneeberger

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation'. Together they form a unique fingerprint.

Medicine and Dentistry